Bristol-Myers Squibb CompanyBMYNYSE
Loading
EPS Diluted Over TimeExpanding
Percentile Rank93
3Y CAGR+5.4%
Year-over-Year Change
Diluted earnings per share
3Y CAGR
+5.4%/yr
vs -0.7%/yr prior
Acceleration
+6.0pp
Accelerating
Percentile
P93
Near historical high
vs 3Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.45 | +178.2% |
| 2024 | -4.41 | -214.2% |
| 2023 | 3.86 | +30.8% |
| 2022 | 2.95 | -5.4% |
| 2021 | 3.12 | +178.4% |
| 2020 | -3.98 | -298.0% |
| 2019 | 2.01 | -33.7% |
| 2018 | 3.03 | +396.7% |
| 2017 | 0.61 | -77.0% |
| 2016 | 2.65 | - |